Combination Pill Improves Adherence in Cardiovascular Disease Patients

Aimee Simone, Assistant Editor
Published Online: Thursday, September 5, 2013
Follow Pharmacy_Times:
Patients with or at high risk for cardiovascular disease who took a pill that combined aspirin, a statin, and 2 antihypertensives had significantly higher adherence levels than those who received usual care. 

After more than a decade of speculation on the possibility of a single pill that combines multiple medications to prevent and treat cardiovascular disease, a European study provides evidence that such a “polypill” may markedly improve adherence and modestly improve blood pressure and cholesterol control in high-risk patients.

The study, published in the September 4, 2013, issue of the Journal of the American Medical Association, analyzed the effect of a fixed-dose combination pill on long-term adherence, systolic blood pressure, and low-density lipoprotein cholesterol (LDL). A total of 2004 patients from England, Ireland, the Netherlands, and India who either had cardiovascular disease or were at high risk for cardiovascular disease were randomly assigned to continue with regular care or to receive a combination pill between July 2010 and July 2011. A trial physician determined whether participants in the combination pill group would receive version 1 (75 mg of aspirin, 40 mg of simvastatin, 10 mg of lisinopril, and 50 mg of atenolol) or version 2 (75 mg of aspirin, 40 mg of simvastatin, 10 mg of lisinopril, and 12.5 mg of hydrochlorothiazide).

Follow-up ranged from 1 to 2 years, and patients visited clinics or participated in telephone interviews at 1 month, 6 months, and 18 months. Blood pressure and fasting lipid levels were measured at baseline, 12 months, and at the end of the study in July 2012. Patients self-reported adherence levels by specifying the number of days they took their medication during the week preceding a clinic visit or phone call.

After 1 month, 97.3% of patients in the combination pill group were adherent, compared with 68.3% of regular care patients. At the end of the study, 86.3% of the combination pill patients remained adherent, compared with just 64.7% of regular care patients. Differences in blood pressure and cholesterol between the two groups were not as marked, but levels for patients in the combination group were still significantly lower than for control patients. On average, systolic blood pressure in patients taking combination pills was 2.6 mm Hg lower and LDL cholesterol was 4.2 mg/dL lower than in those receiving regular care.

The results also indicated no significant difference in serious adverse events between the 2 groups. (Patients in the combination pill group experienced 50 cardiovascular events compared with 35 in the usual care group, but this difference was not statistically significant.)

The authors conclude that fixed-dose combination pills may be a viable solution to improving adherence and cardiovascular health among patients at risk for cardiovascular disease. In an accompanying editorial, however, J. Michael Gaziano, MD, MPH, writes that more research should be conducted among the populations that might benefit the most from the polypill.

“[I]t would be useful to conduct trials in patients who are less adherent to their medications, as well as trials testing whether a combination pill is useful in lower-income countries where costs and systems of delivering preventive medications to appropriate patients are less developed,” he writes.

Until more research confirms the benefits of combination pills, Dr. Gaziano suggests that physicians take an inventory of the medications their cardiovascular patients are taking and remove any that may be unnecessary.

Related Articles
Veterans with post-traumatic stress disorder face greater odds of developing heart failure.
Patients with limited life expectancy may see improvement in their quality of life if they stop taking statins.
As the US Centers for Medicare and Medicaid Services places a greater emphasis on medication adherence through its star ratings, pharmacists and other health care professionals continue to seek ways to improve adherence among seniors.
The 2015 American College of Cardiology Annual Scientific Session and Expo featured the latest discoveries in cardiovascular research.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times